Get started
Work

1770O Refining risk stratification in patients undergoing radiotherapy (RT) and long-term (lt) ADT for high-risk/locally advanced prostate cancer (HR/LA-PC): An individual patient data (IPD) analysis of randomized controlled trials (RCTs) from the ICECaP consortium

Year: 2023
Type: article
DOI: 10.1016/j.annonc.2023.09.2720
Authors: P. Ravi, W. Xie, M.E. Buyse, S. Halabi, P.W. Kantoff, O. Sartor, G. Attard, N.W. Clarke, A. D'Amico, J. Dignam, N.D. James, K. Fizazi, S. Gillessen, W.R. Parulekar, H. Sandler, D. Spratt, M.R. Sydes, B. Tombal, S. Williams, C. Sweeney
Institutions: Dana-Farber Cancer Institute, International Drug Development Institute (Belgium), Duke Medical Center, Mayo Clinic, University College London, Salford Royal NHS Foundation Trust, The Christie NHS Foundation Trust, NRG Oncology, Institute of Cancer Research, Institut Gustave Roussy, Ospedale Regionale di Bellinzona e Valli, Istituto Oncologico della Svizzera Italiana, Canadian Cancer Trials Group, Cedars-Sinai Medical Center, Case Western Reserve University, MRC Clinical Trials Unit at UCL, Medical Research Council, Cliniques Universitaires Saint-Luc, UCLouvain, Peter MacCallum Cancer Centre, The University of Adelaide
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W4387810335
FWCI:
Cites:
Cited by:
Related to: 10